UC-MSC Therapy
Stem cells from umbilical cord | Young cell-derived regenerative medicine
About This Treatment
UC-MSC therapy uses stem cells harvested from umbilical cord at birth—available only once, making cells particularly young and active. Secretes EGF, FGF, VEGF in high quantities.
Supports cellular proliferation and differentiation, promotes wound healing. Suppresses inflammatory responses, improving inflammation-prone aging skin and restoring texture and firmness. Compensates for age-related decline in stem cell function with youthful cells.
Mechanism of Action
UC-MSC-secreted factors (EGF, FGF, VEGF) act on dermal fibroblasts, promoting proliferation, differentiation, and collagen production. Simultaneously produces anti-inflammatory cytokines (IL-10, TGF-β) while suppressing pro-inflammatory ones (IL-6). Reduces skin inflammation, improves barrier function. Promotes neovascularization, enhancing tissue oxygen supply.
Indications
Expected Results
Post-UC-MSC administration, inflammatory markers (CRP, IL-6) decrease. Skin elasticity and hydration improve, sensitive skin calms. Typically perceive improvement at 3-6 months.
Clinical Evidence
Risks & Side Effects
Infection risk during umbilical cord collection (facility-dependent). Cell viability reduction during storage. Post-injection immune response rare but theoretical risk exists due to non-autologous nature.
Interested in this treatment?
Start with an AI skin analysis to check your current skin condition